#ai drug discovery

2 stories

#startups #biotech #business #catalio capital management #clinical trials #deepmind #drug development #enveda #isomorphic labs #nature-derived medicines #series c funding #series e funding

Isomorphic Labs Targets $40B Valuation
Isomorphic Labs, DeepMind's AI drug discovery spinout, aims for $40 billion valuation after May's $2.1 billion funding round.
Dealroom · 1m
Enveda raises $311M to test AI-found drugs
The biotech startup that hunts medicines in nature just doubled its valuation with fresh funding for clinical trials.
TechCrunch · 1m